Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. Annemans

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Pcv93 - Cost-Effectiveness of Guideline Adherence in Coronary Patients: The Impact of the Methodology

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PIN69 Methodological Challenges for Economic Evaluations of Vaccination Programs: The Case of Pertussis Booster Vaccination

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Pcv96 - Healthcare Resource Utlisation in Patients on Lipid-Lowering Therapies Outside of Western Europe: Findings of the International Cholesterol Management Practice Study (Iclps)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cv4 - Patient and Caregiver Indirect Costs After Acute Cardiovascular Events in Europe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmh60 - A Cost-Utility Analysis of a Mental Health Promotion Program in Social Economy Companies in Flanders

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PRM42 Valuation of HR-QoL Utilities by the EQ-5D in a Group of Chronically Ill Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in France: A Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy